Skip to main content
ENDO 2026 Main banner

Emily Stein, MD, MS

Co-Director Skeletal Health and Orthopaedic Research Program
Hospital for Special Surgery
New York, NY, United States

Dr. Emily Stein is Co-Director of the Skeletal Health and Orthopaedic Research Program at the Hospital for Special Surgery. She is also an Associate Professor of Medicine at Weill Cornell Medical College. Dr. Stein received her undergraduate degree from Yale University, where she was elected to Phi Beta Kappa and graduated Magna Cum Laude. She received her medical degree from the Albert Einstein College of Medicine where she received a Rudin Fellowship for academic excellence and was elected to Alpha Omega Alpha. She completed her internship and residency at Columbia Presbyterian Medical Center. She was a fellow in Endocrinology and Metabolism at the combined program at New York Hospital/Weill Cornell Medical Center and Memorial Sloan Kettering Cancer Center. She also completed a Masters Degree in Clinical Investigation at the Cornell Graduate School.

Dr. Stein’s research, supported by the National Institutes of Health and private foundations focuses on bone quality in orthopedic patient populations and glucocorticoid induced osteoporosis. Dr. Stein is leading the FUSED SPINE prospective cohort study investigating novel tools for assessment of bone quality in patients having spine surgery and relationships between pre-operative imaging and surgical outcomes. She also leads the FAST Healing Trial, a randomized placebo controlled clinical trial studying whether abaloparatide treatment improves outcomes after spinal fusion surgery. Dr. Stein is currently Deputy Editor responsible for clinical research content at The Journal for Bone and Mineral Research.

Dr. Stein’s clinical practice is focused on patients with osteoporosis and metabolic bone disease. Dr. Stein has also played a role in shaping evidence based clinical practice decisions in the field, serving as a member of the American Society of Bone and Mineral Research Professional Practice Committee, the International Society of Clinical Densitometry Scientific Advisory Council and the American College of Rheumatology Glucocorticoid Induced Osteoporosis Quality Measure Development Panel.

Disclosure information not submitted.

Presentation(s):